MedX Health (TSXV: MDX) has announced the appointment of Dr. Paul J. Matts, internationally recognized skin scientist, biochemist, and educator, as strategic advisor.
Dr. Matts is an academic and industry leader, as well as a global authority on human skin optics, stratum corneum biology, sun protection and the psychology of skin perception. He has authored more than 65 peer-reviewed publications, delivered more than 150 keynote presentations worldwide, and is widely recognized as a leader in both dermatology and cosmetic science.
Dr. Matt’s pioneering work on MedX’s technology, Spectrophotometric Intracutaneous Analysis (SIAscopy), enabled the first-ever simultaneous, non-invasive measurement of melanin, hemoglobin and collagen, driving powerful new application in both the early detection of malignant melanoma skin cancer and the cosmetic sciences.
“MedX is advancing the early detection of skin cancer at scale using its DermSecure platform, coupled with MedX’s imaging technology (SIAcopy),” said Dr. Matts. “I am delighted to contribute my experience in skin optics, sun protection and perception science to help accelerate MedX’s mission to reduce the global burden of skin cancer and preventable skin disease.”
John Gevisser, CEO of MedX, added, “Dr. Paul Matts is not only one of the world’s foremost authorities on skin science and sun protection, but also an educator and humanitarian who has dedicated his career to improving the lives of others. His expertise will strengthen MedX’s scientific foundation and help advance our goal of delivering accurate, trusted and widely-accessible skin cancer screening and the development of new skin assessment technologies for the health and beauty industry.”
